A detailed history of Coastal Bridge Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 34,817 shares of TAK stock, worth $472,118. This represents 0.14% of its overall portfolio holdings.

Number of Shares
34,817
Previous 34,852 0.1%
Holding current value
$472,118
Previous $450,000 9.78%
% of portfolio
0.14%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.0 - $15.08 $455 - $527
-35 Reduced 0.1%
34,817 $494,000
Q2 2024

Aug 15, 2024

BUY
$12.6 - $13.67 $441 - $478
35 Added 0.1%
34,852 $450,000
Q4 2022

Feb 08, 2023

BUY
$12.42 - $15.62 $288,454 - $362,774
23,225 Added 200.35%
34,817 $543,000
Q2 2022

Nov 15, 2022

SELL
$13.12 - $15.03 $2,020 - $2,314
-154 Reduced 1.31%
11,592 $163,000
Q2 2022

Aug 05, 2022

BUY
$13.12 - $15.03 $154,107 - $176,542
11,746 New
11,746 $165,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Coastal Bridge Advisors, LLC Portfolio

Follow Coastal Bridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.